Phoenix Hostedを用いて成功を達成：リアルワールドのお客様のストーリー

As part of our Phoenix Hosted webinar, we highlighted three customer success stories showcasing the platform’s flexibility and benefits. These real-world examples demonstrate how different organizations leverage Phoenix Hosted to streamline workflows, enhance compliance, and optimize performance.

ソリューション

Preclinical, Early Clinical, Late Clinical, Regulatory

Products

クラウド版：Phoenix Hosted

Clinical-stage biopharma: stability and performance for advanced modeling

A small biopharmaceutical company relies on Phoenix NLME for advanced modeling and simulation. They appreciate the virtualized desktop managed by Certara, ensuring high performance and stability, as well as the convenience of remote job execution. After a two-week evaluation, they transitioned to full production in just four weeks and have been successfully using Phoenix Hosted for over a year.

"Stability is great and easy to use. It's good to have a familiar MS Windows environment. Having used AWS for other modeling platforms, this is by far the best."

Preclinical biopharma: controlled, compliant, and efficient

A Tier 2 biopharmaceutical company with five users needed a secure, controlled environment for NCA analysis and regulatory reporting. With Certara handling hosting, installation, security, and version control, they streamlined workflows and ensured compliance. The integration of PKSubmit enabled high-throughput NCA analyses with CDISC-compliant outputs. Their system went live in June 2024, delivering efficiency and compliance.

Pharmaceutical company: scalable and GxP-ready across departments

A mid-sized pharmaceutical company in the US deployed Phoenix Hosted across preclinical PK and ClinPharm GxP studies for 12 users. Key benefits included technical controls, compliance-ready data management, and system validation by Certara. Their journey—from evaluation in May to full production in January—demonstrates Phoenix Hosted’s scalability. They later expanded their system with NLME licenses and 14 active users.